Tag: shroom-stocks
-
![Mind Cure (MCUR.C) has pivoted a few times, but may finally be onto something with its focus on tech]()
Mind Cure (MCUR.C) has pivoted a few times, but may finally be onto something with its focus on tech
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to raise a considerable amount of cash while having its hands in several different buckets, bringing in $23 million CAD on a bought deal back in February. Mind…
-
![I am anecdotal evidence for Cybin’s (CYBN.NE) plan to target alcoholism with mushrooms]()
I am anecdotal evidence for Cybin’s (CYBN.NE) plan to target alcoholism with mushrooms
Last week Cybin (CYBN.NE) announced it was targetting alcoholism with its novel psychedelic compound CYB003. Another EG staffer wrote a piece last Monday outlining the details of the plan, but I’m going full editorial for this one as I have some experience with the topic. Through a series of psychedelic trips in my teen years,…
-
![Revive Therapeutics (RVV.C) CEO Michael Frank likes the stock, buys the dip]()
Revive Therapeutics (RVV.C) CEO Michael Frank likes the stock, buys the dip
+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or anything, things have been running pretty nicely the past couple of quarters and it was probably time for a correction. Any time a sector emerges this quickly there…
